Related references
Note: Only part of the references are listed.Computational Drug Repositioning: From Data to Therapeutics
M. R. Hurle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Nocodazole is a High-Affinity Ligand for the Cancer-Related Kinases ABL, c-KIT, BRAF, and MEK
Hwangseo Park et al.
CHEMMEDCHEM (2012)
New sources of drugs for hematologic malignancies
Mahadeo A. Sukhai et al.
BLOOD (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2011)
PROMISCUOUS: a database for network-based drug-repositioning
Joachim von Eichborn et al.
NUCLEIC ACIDS RESEARCH (2011)
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
Mohammad H. Pourgholami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
Novel trends in high-throughput screening
Lorenz M. Mayr et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
The fluorometric microculture cytotoxicity assay
Elin Lindhagen et al.
NATURE PROTOCOLS (2008)
Future of toxicology-iron chelators and differing modes of action and toxicity: The changing face of iron chelation therapy
Danuta S. Kalinowski et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis
MH Pourgholami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
A comparative study of albendazole and mebendazole-induced, time-dependent oxidative stress
C Locatelli et al.
REDOX REPORT (2004)
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
MH Pourgholami et al.
CANCER LETTERS (2001)
Pilot study of albendazole in patients with advanced malignancy - Effect on serum tumor markers/high incidence of neutropenia
DL Morris et al.
ONCOLOGY (2001)
Share Paper
